维普中文期刊产品整合服务
815篇 您的检索式:作者名="Thompson V"
    题名 作者 年代 出处 被引量
1Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience显示文摘AIM To evaluate the long-term treatment outcomes of tenofovir therapy in patients in a real world Australian tertiary care setting.METHODS We performed a retrospective analysis of treatment outcomes among treatment-na?ve and treatment-experienced patients receiving a minimum 3 mo tenofovir therapy through St Vincent's Hospital Melbourne, Australia. We included patients receiving tenofovir [tenofovir disoproxil fumarate(TDF)] monotherapy, as well as patients treated with TDF in combination with a second antiviral agent. Patients were excluded if they demonstrated human immune-deficiency virus/hepatitis C virus/hepatitis delta virus coinfection or were less than 18 years of age. We considered virological and biochemicalresponse, as well as safety outcomes. Virological response was determined by measurement of hepatitis B virus(HBV) DNA using sensitive assays; biochemical response was determined via serum liver function tests; histological response was determined from liver biopsy and fibroscan; safety analysis focused on glomerular renal function and bone mineral density. The primary efficacy endpoint was complete virological suppression over time, defined by HBV DNA < 20 IU/m L. Secondary efficacy endpoints included rates of biochemical response, and HB e antigen(HBe Ag)/HB surface antigen loss and seroconversion over time.RESULTS Ninety-two patients were identified who fulfilled the enrolment criteria. Median follow-up was 26 mo(range 3-114). Mean age was 46(24-78) years, 64(70%) were male and 77(84%) were of Asian origin. 55(60%) patients were treatment-na?ve and 62 patients(67%) were HBe Ag-negative. Complete virological suppression was achieved by 45/65(71%) patients at 12 mo, 37/46(80%) at 24 mo and 25/28(89%) at 36 mo. Partial virological response(HBV DNA 20-2000 IU/m L) was achieved by 89/92(96.7%) of patients. Multivariate analysis showed a significant relationship between virological suppression at end of follow-up and baseline HBV DNA level(OR = 0.897, 95%CI: 0.833-0.967, P = 0.0046) and HBe Ag positive status(OR = 0.373, 95%CI: 0.183-0.762, P = 0.0069). There was no difference in response comparing treatment-na?ve and treatment-experienced patients. Three episodes of virological breakthrough occurred in the setting of noncompliance. Tenofovir therapy was well tolerated.CONCLUSION Tenofovir is an efficacious, safe and well-tolerated treatment in an Australian real-world tertiary care setting. Our data are similar to the reported experience from registration trials.Grace C Lovett Tin Nguyen David M Iser Jacinta A Holmes Robert Chen Barbara Demediuk Gideon Shaw Sally J Bell Paul V Desmond Alexander J Thompson 2017World Journal of Hepatology2017,9,1:7
2Re-discovering PDE3 inhibitors-new opportunities for a long neglected target显示文摘Thompson P E Manganiello V Degerman E 2007Cur TopicsMed Chem2007,7,:1
3Margin Fit of CAD/CAM Produced Crowns 显示文摘Rekow E D Thompson V P Yang H S 1991Dental Research1991,70,434:1
4The Computer-Aided Design of Modular Fixturing Systems 显示文摘Grippo P M Gandhi M V Thompson B S 1987The Int J ofAdv ManufTechnology1987,2,2:1
5显示文摘Rasmussen S C Thompson D W Singh V 1996Inorg Chem1996,35,12:1
6Lipoxygenase-generated hydroperoxides account for the nonphysiological features of ethylene formation from 1-aminocyclopropane-1-carboxylic acid by microsomal membranes of carnations显示文摘Lynch D V Sridhara S Thompson J E 1995Planta1995,164,:1
7Comeal thickness meas-urements with the Orbscan Topography System and ultrasonicpachymetry 显示文摘Yaylali V Kaufman SC Thompson HW 1997J Cataract Refract Surg1997,23,9:1
8Is Z- disk degradation responsible for postmortem tenderiza- tion显示文摘Taylor R G Geesink G H Thompson V F 1995Journal of Animal Science1995,73,4:1
9A technique for the mass propagation of the DD-136 nematode 显示文摘Dutky S R Thompson J V Cantwell G E 1964Journal of In- vertebrate Pathology1964,6,:1
10Computational fluid dynamic analysis and design optimization of jet pumps 显示文摘Fan J Eves J Thompson H M Toropov V V Kapur N Copley D Mincher A 2011Computers Fluids2011,46,:1
11Transition to chaos in acoustically driven flow(acoustic stream)显示文摘Thompson C Mulpur A Mehta V 1991The Journal of the Acoustical Society of America1991,90,:1
12Evaluation of differences in percentage of international normalized ratios in range between pharmacist-led and physician-led anticoagulation management services显示文摘Gupta V Kogut SJ Thompson S 2015J Pharm Pract2015,28,3:1
13Optical deconstruction of parkinsonian neural circuitry 显示文摘Gradinaru V Mogri M Thompson KR 2009Science2009,324,5925:1
14Differential screening and suppression snbtractive hybridazation identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line 显示文摘Kuang W W Thompson D A Hoeh R V Weigel R J 1998Nucleic Acids Res1998,26,:1
15Folding dynamics and mechanism of beta-hairpin formation显示文摘Munoz V Thompson P A Hofrichter J 1997Nature1997,390,:1
16Parameters of superpopulation and survey population:Their relationship and estimation显示文摘Godmanbe V P Thompson M E 1986Int Statist Rev1986,54,:1
17The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-depriva- tion-induced neuronal death 显示文摘Hongisto V Vainio JC Thompson R 2008Mol Cell Biol2008,28,5:1
18Cost-effectiveness and efficiency of shockwave lithotripsy vs flexible ureteroscopic holrnium:yttrium-alumiu- lure-garnet laser lithotripsy in the treatment of lower pole renal calculi 显示文摘Koo V Young M Thompson T 2011B J U Int2011,108,:1
19Characterization of Anthocyanins and Anthocyanidins in Purple-Fleshed Sweetpotatoes by HPLC-DAD/ESI-MS/MS显示文摘Truong V Deighton N Thompson R T 2010Journal of Agricultural and Food Chemistry2010,58,2:1
20Dependence of the electromigration flux on the crystallographic orientations of different grains in polycrystalline copper interconnects显示文摘CHOI Zung-sun MONIG REINER THOMPSON C V 2007Appl Phys Lett2007,90,24:1
返回顶部 每页显示:
共41页 首页 上一页 第1页 下一页 末页 /41 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费